[Aclarubicin in metastatic thyroid cancer: initial clinical experience].
Langsteger
W
W
Lind
P
P
Eber
O
O
Költringer
P
P
Klima
G
G
D015250:Aclarubicin; D000230:Adenocarcinoma / Q000188:drug therapy; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009279:Naphthacenes / Q000627:therapeutic use; D013964:Thyroid Neoplasms / Q000188:drug therapy*
D000903:Antibiotics, Antineoplastic; D009279:Naphthacenes; D015250:Aclarubicin
Aclarubicin bei metastasierendem Schilddrüsenkarzinom: Erste klinische Erfahrungen.